2022-2023 Legislative Agenda
MedTech’s 2022-2023 Agenda to Improve the Health of New Yorkers and Grow the Bio/Med Industry
1. Strengthen the Public Health Infrastructure
- Convene a Public Health System Work Group of public and private stakeholders to make recommendations to the Governor and the Commissioner of Health to improve the state’s public health system.
- Establish and fund a statewide Infectious Disease Research and Data Sharing Collaborative to support contact tracing innovation and facilitate development of new diagnostics and treatments.
- Reauthorize and expand the Biodefense Commercialization Fund to encourage and accelerate the development and commercialization of solutions for serious infectious disease threats, while fostering the creation of new life science businesses and supporting industry growth.
2. Expand Access to Home-Based and Remote Healthcare and Monitoring
- Provide capital grants to health care providers for projects which improve access to telehealth services.
- Study the feasibility of a voucher or subsidy program by which low-income individuals and others who currently lack connectivity can access telehealth services.
- Develop a Telehealth Resource Center where consumers and providers can find educational material, and which assists providers in the implementation of telehealth services including a telehealth readiness assessment tool.
- Create a funding mechanism to support the development of new tools, devices and services that provide distance care and/or remote patient monitoring capabilities.
3. Increase Clinical Trial Diversity and Decentralization
- Create an institutional review board, provider and consumer decentralized clinical trial education material to standardize and facilitate greater clinical trial participation.
- Identify and address impediments to decentralized clinical trials (e.g., drug supply chain and telemedicine laws and technical limitations).
- Develop clinical trial education material in multiple languages and in different media for patients.
- Develop searchable data on sites and healthcare providers serving diverse populations.
4. Protect Patient Privacy Without Stifling Innovation
- Maintain a fair and patient-protective regulatory climate for use and stewardship of protected data and information.
- Recognize that patients and their providers have unique information sharing needs and that established HIPPA safeguards provide robust protection of sensitive data.
- Ensure that consumer privacy protections don’t impede the development and implementation of healthcare innovation.
5. Prioritize Life Sciences Workforce Development
- Create a Life Sciences Workforce Development Response Team to provide customized training tailored to the needs of the state’s life sciences companies.
- Establish a Higher Education/Industry Life Sciences Consortium to address the education and training challenges facing the industry.
- Expand incentives to support internships, apprenticeships and other workforce development programs.
- Encourage the NYS Office of Strategic Workforce Development and the Regional Economic Councils to work together to focus on the specific workforce needs of the Life Sciences industry.
6. Employ Existing Economic Development Tools to Address the Unique Needs of the Life Sciences Industry
- Encourage the Regional Economic Development Councils to coordinate their funding applications to take advantage of super-regional life sciences opportunities.
- Use development and tax incentive tools to ensure that New York’s medical device industry has secured access to semiconductor chips and other domestically produced nanotechnology innovations.
- Provide capital funding for the expansion of incubators devoted to biotechnology innovation, and for the construction of laboratories and workspaces appropriate for emerging life sciences companies.
7. Create an Innovation-Focused Tax Policy
- Expand corporate, manufacturing and investment credits to secure New York’s future as a leader in the biomedical and healthcare fields.
- Review and reform New York’s tax laws related to insure competitiveness with the nation’s leading centers of biomedical innovation.
- Commit to ensuring that New York’s business climate for life sciences companies is first in the nation.